01—Abstract
Summary
Summary of the 10-Q filed May 9, 2005. Cited figures are marked; the original filing is the authoritative source.
Procter & Gamble Co. (PG) reported strong financial results for the nine months ended March 31, 2005, with net sales increasing 11% to $42.5 billiona and net earnings up 13% to $5.76 billion, or $2.10 per diluted share.
The company experienced robust unit volume growth of 9% across all segments and geographies, driven by strong performance in Beauty Care and Health, Baby & Family Care. Organic sales growth of 7% highlights the underlying strength of the business. A significant development during the period was the announcement of the proposed acquisition of The Gillette Company for approximately $54 billionb in a stock-for-stock exchange.
This transformative deal is expected to close in Fall 2005, subject to shareholder and regulatory approvals. The company also continued its share repurchase program, buying back shares to offset dilution and in anticipation of the Gillette acquisition.
02—Key points
Key Highlights
- Net sales for the nine months ended March 31, 2005, increased by 11% to $42.48 billion, compared to $38.45 billion in the prior year.
- Net earnings rose by 13% to $5.76 billion for the nine-month period, translating to diluted EPS of $2.10, a 15% increase.
- Unit volume grew by 9% for the nine months and 6% for the third quarter, indicating broad-based consumer demand across segments.
- The company announced a definitive agreement to acquire The Gillette Company for approximately $54 billion in a stock-for-stock transaction, expected to close in Fall 2005.
- The balance sheet shows a significant increase in cash and cash equivalents to $7.07 billion from $4.23 billion at the prior fiscal year-end, partly due to the reclassification of certain investments.
- Operating income saw a healthy increase of 12% for the nine months to $8.63 billion, demonstrating effective cost management alongside revenue growth.
- Free cash flow productivity for the nine months was 91%, meeting the company's long-term target of 90% or greater.
03—Questions
Frequently Asked Questions
What is the company's outlook based on this filing?
The company demonstrated strong top-line growth and earnings expansion in the nine months ended March 31, 2005, driven by solid unit volume increases across its segments. The announced acquisition of Gillette is a major strategic move that is expected to create a larger, more diversified company. However, the company is also navigating challenges like higher commodity costs, which are expected to impact gross margins.
How will the acquisition of Gillette impact Procter & Gamble?
The acquisition of Gillette is a transformative event. It is expected to significantly increase the scale and scope of Procter & Gamble's operations, particularly in grooming, batteries, and oral care. The company anticipates completing the acquisition in Fall 2005, subject to approvals. The financial impact will be substantial, with a total consideration of approximately $54 billion and an associated share repurchase program.
What are the key financial performance indicators highlighted in this report?
Key financial highlights include an 11% increase in net sales to $42.48 billion and a 13% increase in net earnings to $5.76 billion for the nine months. Unit volume growth of 9% and organic sales growth of 7% indicate strong underlying business performance. Free cash flow productivity of 91% also stands out as a positive indicator.
Are there any significant risks or uncertainties mentioned by the company?
Yes, the company lists several factors that could impact future results. These include competitive activity, the successful integration of acquisitions (notably Gillette), customer relationships, supply chain management, regulatory and legal matters, cost management, currency and interest rate fluctuations, global economic and political uncertainty, and commodity price increases. The company also notes ongoing analysis of the American Jobs Creation Act of 2004 regarding potential repatriation of foreign earnings.
04—Continue